Press Releases

Mural Health and ProofPilot Partner to Streamline Payments and Provide More Patient Choice

Mural Health, a clinical trials technology company that improves the patient and caregiver experience in order to improve enrollment rates, participant retention, and increase protocol compliance and ProofPilot, the industry's first digital protocol automation platform for clinical trial, today announced a strategic partnership to further advance clinical trial operations for life science customers. Through this partnership, Mural Health’s Mural Link™ platform and ProofPilot’s platform work together to progress clinical operations and materially improve the efficiency, and outcomes, of global clinical trials.

Clinion Launches Revolutionary AI-Powered Medical Coding Solution for Clinical Trials

[London, UK] - Clinion, a leading provider of eClinical solutions, has announced the launch of its new AI-powered medical coding solution. This innovative solution is designed to transform the medical coding process for clinical trials, offering a faster, more efficient, and more accurate way to code medical data.

NDA Group announces expansion of its Advisory Board adding expertise in bioanalysis and immunogenicity assessment

NDA Group is thrilled to announce the expansion of their Advisory Board with the appointment of Marianne Scheel Fjording, Ph.D.

Optical Brighteners, Plasticizers, and Antioxidants as Polymer Stabilizers

Biopharma PEG To Attend PEGS Boston Summit 2023

Huateng Pharma Announced To Present CPhI North America In April 2023

Curebase Selected Among Y Combinator’s Top Private Companies of 2023

DCT platform company places in top 6% of private companies; recognized for end-to-end clinical trial execution built on cutting-edge software

CD ComputaBio Introduces AutoDock, a Powerful Molecular Docking Software

TransCure bioServices delivers CDX mouse models to advance AML preclinical studies

TransCure bioServices has developed cell line-derived xenograft (CDX) mouse models that will change how researchers tackle the preclinical studies of cancer therapies to treat acute myeloid leukemia (AML).

Creative Enzymes Releases Restriction Enzymes for Molecular Biology Research

Alfa Chemistry to Present at the Upcoming ACS Spring 2023 Conference

Alfa Chemistry, a chemical company focused on supplying high-quality chemicals and materials for both academia and the industry, today announced that members of its Senior Management Team are scheduled to participate in the upcoming ACS Spring 2023 Conference in March at Indiana Convention Center, located in 100 S Capitol Ave, Indianapolis, IN 46225.

Alfa Chemistry Announces to Participate in the Upcoming Pittcon Conference & Exposition 2023

The New York-based chemical vendor Alfa Chemistry recently announced its attendance at the upcoming Pittcon Conference & Exposition 2023. This five-day event will take place at Pennsylvania Convention Center from 18th – 22nd March 2023.

Creative Proteomics Enhances Your Project with Cell Surface Proteomics Service

Creative Proteomics Cytokine Boosts Cancer Research with Cancer Cytokines Assay

Pronalyse Announces the Launch of Epitope Mapping Service Utilizing HDX-MS Technology

CD Formulation Upgrades Its Database of Pharmaceutical Excipients, Cosmetic Ingredients, and Food Ingredients

Chiral Derivatization Reagents, Cosmetic Additives, and Organic Field Effect Transistor Materials

Jumo Health Launches Suite of Services to Drive Health Equity in Clinical Trials

Expanded offerings will increase Black representation in clinical trials, ensuring that new medicines are safe and effective for people of color.

IntegrateRNA Offer Custom Production of Peptide-oligonucleotide Conjugates (POC) to Optimize Therapeutic Research

Microbiosci Offers Yeast Cell Bank Characterization Service to Value Microbial Cell Banks